Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M S Müller

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Leukemia|March 18, 2005
Severe irreversible bilateral hearing loss after bortezomib (VELCADE) therapy in a multiple myeloma (MM) patientM Engelhardt, A M S Müller, W Maier, et al.
Oncogene|July 8, 2008
Complementing mutations in core binding factor leukemias: from mouse models to clinical applicationsA M S Müller, J Duque, J A Shizuru, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Leukemia|March 18, 2005
Severe irreversible bilateral hearing loss after bortezomib (VELCADE) therapy in a multiple myeloma (MM) patientM Engelhardt, A M S Müller, W Maier, et al.
Oncogene|July 8, 2008
Complementing mutations in core binding factor leukemias: from mouse models to clinical applicationsA M S Müller, J Duque, J A Shizuru, et al.
Pageof 1